 |
 |
>From: WE MOVE <[log in to unmask]> >Subject: Early Ropinirole Reduces Dyskinesias >Date: Wed, 24 May 2000 16:22:14 -0500 > >A five-year study of the incidence of dyskinesia in patients with early >Parkinson's disease who were treated with ropinirole or levodopa >O Rascol, DJ Brooks, AD Korczyn, PP De Deyn, CE Clarke, AE Lang, for the >056 Study Group >NEJM 2000;342:1484-91 > >Early use of ropinirole alone or in combination with levodopa reduces the >incidence of dyskinesia in patients with Parkinson's disease, according to >this double-blind study. The data in this study were originally presented >at the XIIIth International Congress on Parkinson's Disease, July 24-28, >1999, Vancouver, Canada, as reported by E-MOVE in >http://www.wemove.org/ema/em_pd_01.html. > >Copyright 2000 WE MOVE >Editor: Richard Robinson ([log in to unmask]) > >This service is provided free of charge to the Internet community, >courtesy of WEMOVE.org. This document may be freely redistributed by >email only in its unedited form. We encourage you to share it with your >colleagues. > >E-MOVE archives, plus information on subscribing, are >available at http://www.wemove.org/emove. >To unsubscribe, send an e-mail to [log in to unmask], >with "unsubscribe e-move" in the message body. > >E-MOVE is a service of WE MOVE (Worldwide Education and Awareness for >Movement Disorders) >204 West 84th Street >New York, NY 10024 > >TEL 800-437-MOV2 >TEL 212-241-8567 >FAX 212-987-7363 >http://www.wemove.org janet paterson 53 now / 41 dx / 37 onset 613 256 8340 / PO Box 171 Almonte Ontario K0A 1A0 Canada visit my website "a new voice" at: http://www.geocities.com/janet313/